Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Escalation Study of BIIB014 in Moderate to Late-Stage Parkinson's Disease on Levodopa
2006-003490-27Phase 2Terminated
- Sponsor
- Biogen
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing BIIB014 + levodopa with Placebo + levodopa (2 arms). Primary endpoints: Safety and tolerability of BIIB014 and Pharmacokinetics of BIIB014 and its N-acetyl metabolite. Started Sep 2006; status: terminated.
02
Drugs
vipadenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-003490-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003490-27.